AdaptHealth Corp. reports developments tied to its healthcare-at-home business, which provides home medical equipment, medical supplies and related services. The company’s updates commonly address its Sleep Health, Respiratory Health, Diabetes Health and Wellness at Home categories, including sleep therapy equipment and supplies for obstructive sleep apnea, respiratory services, diabetes-related supplies and in-home wellness offerings.
Recurring AdaptHealth news also covers quarterly and annual results, financial guidance, patient census trends, digital patient engagement through myApp, referral and payor relationships, capitated partnerships, acquisitions and dispositions, credit facility activity, debt ratings and investor conference participation. The company serves Medicare, Medicaid and commercial insurance beneficiaries through a national operating network.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
AdaptHealth Corp. (NASDAQ: AHCO) will announce its Q1 2023 financial results on May 9, 2023, before market opening. The company's management will host a teleconference at 8:30 a.m. ET to discuss these results and business activities with investors and analysts. Interested parties can join the call by calling (800) 245-3047 domestically or (203) 518-9765 internationally, referencing Conference ID: AHCO1Q23. Additionally, a replay of the call will be available for six months on the company's website under the 'Investor Relations' section. AdaptHealth specializes in healthcare-at-home solutions, providing medical equipment and supplies to help patients manage chronic conditions, serving around 3.9 million patients annually across 725 locations in 47 states.
AdaptHealth Corp. (NASDAQ: AHCO) reported its financial results for Q4 and fiscal year 2022, highlighting a net revenue increase of 21% year-over-year, reaching $3.160 billion to $3.240 billion for 2023. Despite a strong revenue growth of 11.1% in Q4, net income fell to $69.3 million, down from $156.2 million in 2021. Adjusted EBITDA in 2022 was $593.8 million, while Q4 EBITDA dropped to $146.0 million. The company aims to implement cost containment programs to align with updated guidance. CEO Steve Griggs emphasized strategic advancements, including a merger integration with AeroCare and commitment to healthcare solutions for chronic patients.
AdaptHealth Corp. (NASDAQ: AHCO) will announce its fourth quarter and full year 2022 financial results on February 28, 2023, prior to market opening. The management team will hold a teleconference at 8:30 a.m. ET to discuss financial metrics and business activities with analysts and investors. Interested parties can join the call via phone, using the specified domestic and international numbers, or by registering for the webcast. AdaptHealth provides patient-centered healthcare-at-home solutions, including home medical equipment and supplies, serving approximately 3.9 million patients annually through a network of over 750 locations across 47 states.
AdaptHealth Corp. (NASDAQ: AHCO) announced its initial guidance for fiscal year 2023, projecting net revenue between $3.210 billion and $3.290 billion, alongside Adjusted EBITDA estimates of $690 million to $750 million. Factors influencing this guidance include changes in reimbursement and regulatory frameworks. For fiscal year 2022, anticipated net revenue is projected near $3.010 billion, with Adjusted EBITDA near $620 million. The full results for 2022 will be released on February 28, 2023.